{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:06:42Z","timestamp":1790273202003,"version":"4.1.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"13","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100005632","name":"Polish National Centre for Research and Development","doi-asserted-by":"publisher","award":["ERA-CVD\/Gut-brain\/8\/2021"],"award-info":[{"award-number":["ERA-CVD\/Gut-brain\/8\/2021"]}],"id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,24]]},"DOI":"10.1093\/cvr\/cvag176","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:38:09Z","timestamp":1790077089000},"page":"1728-1731","source":"Crossref","is-referenced-by-count":0,"title":["From one plaque to many: the coming tsunami of pan-vascular disease: bringing pan-vascular disease to the centre of cardiovascular prevention"],"prefix":"10.1093","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5517-994X","authenticated-orcid":false,"given":"Vladyslav","family":"Kyslyi","sequence":"first","affiliation":[{"name":"Department of Internal and Agricultural Medicine, Jagiellonian University Medical College , Wroc\u0142awska 1-3, Krakow 30-901, Poland"},{"name":"Department of Cardiac Surgery and Transplantation, St. John Paul II Hospital , Krak\u00f3w ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5039-7849","authenticated-orcid":false,"given":"Tomasz J","family":"Guzik","sequence":"additional","affiliation":[{"name":"Department of Internal and Agricultural Medicine, Jagiellonian University Medical College , Wroc\u0142awska 1-3, Krakow 30-901, Poland"},{"name":"BHF Centre for Research Excellence, Centre for Cardiovascular Sciences, The University of Edinburgh , 47 Little France Crescent, Edinburgh EH16 4TJ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"2026092413233633400_cvag176-B1","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.jacc.2025.08.015","article-title":"Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990\u20132023","volume":"86","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2026092413233633400_cvag176-B2","first-page":"e56","article-title":"Multimorbidity predicts functional decline in community-dwelling older adults: prospective cohort study","volume":"65","author":"St John","year":"2019","journal-title":"Can Fam Physician"},{"key":"2026092413233633400_cvag176-B3","doi-asserted-by":"crossref","first-page":"e2218307","DOI":"10.1001\/jamanetworkopen.2022.18307","article-title":"Prevalence and vascular distribution of multiterritorial atherosclerosis among community-dwelling adults in southeast China","volume":"5","author":"Pan","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026092413233633400_cvag176-B4","doi-asserted-by":"crossref","first-page":"e007385","DOI":"10.1161\/CIRCINTERVENTIONS.119.007385","article-title":"Polyvascular disease: reappraisal of the current clinical landscape","volume":"12","author":"Gutierrez","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"2026092413233633400_cvag176-B5","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"2026092413233633400_cvag176-B6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11883-011-0173-4","article-title":"Genome-wide association studies in atherosclerosis","volume":"13","author":"Sivapalaratnam","year":"2011","journal-title":"Curr Atheroscler Rep"},{"key":"2026092413233633400_cvag176-B7","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","article-title":"Global burden of cardiovascular diseases and risks, 1990\u20132022","volume":"82","author":"Mensah","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026092413233633400_cvag176-B8","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/cvr\/cvaf119","article-title":"A comprehensive review\/expert statement on environmental risk factors of cardiovascular disease","volume":"121","author":"M\u00fcnzel","year":"2025","journal-title":"Cardiovasc Res"},{"key":"2026092413233633400_cvag176-B9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/cvr\/cvae082","article-title":"New insight into air pollution-related cardiovascular disease: an adverse outcome pathway framework of PM2.5-associated vascular calcification","volume":"120","author":"Ding","year":"2024","journal-title":"Cardiovasc Res"},{"key":"2026092413233633400_cvag176-B10","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"2026092413233633400_cvag176-B11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41569-023-00941-8","article-title":"Socioeconomic inequalities in cardiovascular disease: a causal perspective","volume":"21","author":"Bann","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"2026092413233633400_cvag176-B12","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1093\/cvr\/cvaf176","article-title":"Diet and sex inequities in ischemic heart disease mortality across Europe: findings from the global burden of disease study","volume":"121","author":"Bugiardini","year":"2025","journal-title":"Cardiovasc Res"},{"key":"2026092413233633400_cvag176-B13","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/cvr\/cvaf045","article-title":"Upfront lipid-lowering combination therapy in high cardiovascular risk patients: a route to effective atherosclerotic cardiovascular disease prevention","volume":"121","author":"Banach","year":"2025","journal-title":"Cardiovasc Res"},{"key":"2026092413233633400_cvag176-B14","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/eurjpc\/zwae281","article-title":"Global burden of cardiovascular diseases: projections from 2025 to 2050","volume":"32","author":"Chong","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"2026092413233633400_cvag176-B15","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/cvr\/cvaf182","article-title":"Global, regional, and national burden of aortic aneurysm in the elderly from 1990 to 2021, and projections to 2050: a systematic analysis based on the 2021 Global Burden of Disease Study","volume":"121","author":"Hu","year":"2025","journal-title":"Cardiovasc Res"},{"key":"2026092413233633400_cvag176-B16","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"key":"2026092413233633400_cvag176-B17","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.jacc.2018.03.008","article-title":"Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial","volume":"71","author":"Anand","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026092413233633400_cvag176-B18","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N Engl J Med"},{"key":"2026092413233633400_cvag176-B19","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk)","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation"},{"key":"2026092413233633400_cvag176-B20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/122\/13\/1728\/71383003\/cvag176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/122\/13\/1728\/71383003\/cvag176.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:23:44Z","timestamp":1790270624000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/122\/13\/1728\/8833921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":20,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,9,24]]},"published-print":{"date-parts":[[2026,9,24]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvag176","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,8]]}}}